Funded Tech Companies
ImmunityBio
ImmunityBio, operating out of San Diego, raised money from Oberland Capital.
Company Overview
Company Name
ImmunityBio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3530 John Hopkins Court
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
ImmunityBio, Inc. is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Our approach harnesses both the adaptive and innate immune systems with the goal of restoring immune function and generating lasting immunological memory in patients. At the core of our strategy is the Cancer BioShield� platform, which is designed to stimulate critical lymphocytes, including natural killer (NK) cells, cytotoxic T cells, and memory T cells via our proprietary IL-15 receptor superagonist, ANKTIVA® (nogapendekin alfa inbakicept).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Patrick Soon-Shiong
Chief Executive Officer
Rich Adcock
Chief Financial Officer
David Sachs
Chief Marketing Officer
Sarah Singleton
Chief Medical Officer
Sandeep Reddy
Chief Medical Officer
Leonard Sender
Chief Technical Officer
Enrique Diloné
Vice President
Matthew Hilman
VP - Human Resources
Emily Arison
VP - Product Management
Elizabeth Gabitzsch
VP - Product Management
Manju Saxena
VP - Regulatory Affairs
Bruce Brown
VP - Regulatory Affairs
Charles Garlisi
VP - Regulatory Affairs
Barry Simon
Company Investors
- Oberland Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs